Financial News
Articles published by Telix Pharmaceuticals Limited
Illuccix® Approved in the United Kingdom
February 12, 2025
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
Illuccix® Receives European Approval
January 16, 2025
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
January 13, 2025
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
December 29, 2024
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
November 18, 2024
Telix ADSs Commence Trading on Nasdaq
November 13, 2024
Telix Files Form 20-F Registration Statement for Nasdaq ADS
October 17, 2024
Telix Q3 2024 Business Update – Quarterly Revenue Exceeds AU$200M
October 17, 2024
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
September 17, 2024
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
